Nuveen Churchill Direct Lending Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Nuveen Churchill Direct Lending Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.61M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $116.32M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $75.94M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $17.29M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $27.27M | Feb 27, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $194.16M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($297.20M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($369.53M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | ($427.84M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($389.12M) | Feb 27, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.05B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.14B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.73B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.25B | Feb 27, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.18B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.17B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $982.98M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $729.00M | Feb 27, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $875.18M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $970.32M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $747.89M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $524.96M | Feb 26, 2026 |
| FY2025 | Dec 31, 2021 | $374.05M | Feb 26, 2026 |
| FY2025 | Dec 31, 2020 | $157.64M | Feb 26, 2026 |
| FY2025 | Dec 31, 2019 | $66.21M | Feb 26, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($55.71M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($26.50M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($29.25M) | Feb 26, 2026 |
| FY2023 | Dec 31, 2022 | ($23.93M) | Feb 27, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $43.25M | Feb 27, 2025 |
| FY2024 | Dec 31, 2023 | $67.40M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $39.27M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $35.19M | Feb 27, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.11B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $951.88M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $705.45M | Feb 27, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 27, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 27, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 49.39M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 53.39M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 41.24M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | 28.65M | Feb 26, 2026 |
| FY2025 | Dec 31, 2021 | 19.29M | Feb 26, 2026 |
| FY2025 | Dec 31, 2020 | 8.41M | Feb 26, 2026 |
| FY2025 | Dec 31, 2019 | 3.31M | Feb 26, 2026 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $102.25M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $95.23M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $63.19M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $34.66M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $14.71M | Feb 27, 2024 |